176 related articles for article (PubMed ID: 7689205)
1. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia.
Hamer AW; Strathmore N; Vohra JK; Hunt VD
Pacing Clin Electrophysiol; 1993 Jul; 16(7 Pt 1):1394-400. PubMed ID: 7689205
[TBL] [Abstract][Full Text] [Related]
2. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of intravenous sotalol for termination of paroxysmal supraventricular tachycardia. The Sotalol Versus Placebo Multicenter Study Group.
Jordaens L; Gorgels A; Stroobandt R; Temmerman J
Am J Cardiol; 1991 Jul; 68(1):35-40. PubMed ID: 2058557
[TBL] [Abstract][Full Text] [Related]
4. Failure of episodic high-dose oral verapamil therapy to convert supraventricular tachycardia: a study of plasma verapamil levels and gastric motility.
Hamer AW; Tanasescu DE; Marks JW; Peter T; Waxman AD; Mandel WJ
Am Heart J; 1987 Aug; 114(2):334-42. PubMed ID: 3604891
[TBL] [Abstract][Full Text] [Related]
5. Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamil.
Rose JS; Bhandari A; Rahimtoola SH; Wu D
Am Heart J; 1986 Oct; 112(4):759-65. PubMed ID: 3766376
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
Alboni P; Tomasi C; Menozzi C; Bottoni N; Paparella N; Fucà G; Brignole M; Cappato R
J Am Coll Cardiol; 2001 Feb; 37(2):548-53. PubMed ID: 11216977
[TBL] [Abstract][Full Text] [Related]
7. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
[TBL] [Abstract][Full Text] [Related]
8. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
Sung RJ; Tan HL; Karagounis L; Hanyok JJ; Falk R; Platia E; Das G; Hardy SA
Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
10. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
11. Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Manz M; Lüderitz B
Eur Heart J; 1993 Sep; 14 Suppl E():91-8. PubMed ID: 8223763
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
Dorian P; Naccarelli GV; Coumel P; Hohnloser SH; Maser MJ
Am J Cardiol; 1996 Jan; 77(3):89A-95A. PubMed ID: 8607397
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
[TBL] [Abstract][Full Text] [Related]
14. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
Kim SS; Lal R; Ruffy R
Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
[TBL] [Abstract][Full Text] [Related]
15. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
16. Intravenous flecainide acetate for supraventricular tachycardias.
Hellestrand KJ
Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
[TBL] [Abstract][Full Text] [Related]
17. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]